The mitochondrial uncoupling protein (UCP2) is expressed in selected regions of the brain. Here we demonstrate that upregulation of UCP2 is part of a neuroprotective set of responses to various cellular stresses in vitro and in vivo. PC12 cells, when transfected with UCP2, were protected against free radical-induced cell death. Seizure activity was associated with elevated UCP2 levels and mitochondrial uncoupling activity. In transgenic mice that expressed UCP2 constitutively in the hippocampus before seizure induction, a robust reduction in cell death was seen. Because UCP2 increased mitochondrial number and ATP levels with a parallel decrease in free radical-induced damage, it is reasonable to suggest that mitochondrial UCPs precondition neurons by dissociating cellular energy production from that of free radicals to withstand the harmful effects of cellular stress occurring in a variety of neurodegenerative disorders, including epilepsy. (Endocrinology 144: 5014 -5021, 2003)
M ITOCHONDRIAL ENERGY HOMEOSTASIS is an
important determinant of a cell's ability to withstand stress. Although adequate levels of ATP are essential for cell survival, mitochondrial energy production also generates free radicals that are toxic. Hence, to minimize cell death it would be advantageous to dissociate cellular ATP production from that of free radicals.
Uncoupling proteins (UCPs) can provide a controlled leak of protons across the inner membrane of the mitochondrion and thus uncouple oxidative phosphorylation from respiration, with a concomitant decrease in the inner mitochondrial membrane potential (1) (2) (3) (4) (5) (6) and free radical generation (7, 8) .
In vivo activation of UCPs that may require fatty acids, cofactors, and superoxides (9 -15) will also alter ATP and calcium pools within neurons, with potential effects on activity and susceptibility to toxic stimuli.
UCP2 is the only one of the three closely related, suggested physiological uncouplers (UCP1 to UCP3) (14) that is expressed in many regions of the central nervous system of both rodents and primates (16 -18). UCP2 expression and activity are sensitive to environmental conditions and are increased, for example, after either acute brain injury (19) or irradiation of tumor cell lines (20) . However, it is not yet clear whether this is part of a cell death response or a cell rescue response (see Refs. 19 vs. 20) . Although increasing expression of UCP2 may be correlated with initiation of apoptotic responses in lymphoma cell lines (20), found that a controlled decrease in neuronal mitochondrial membrane potential (an event that could occur due to functioning UCP2) can diminish damaging calcium influx during excitotoxic insults or repetitive, high frequency firing, such as seizure activity. In addition, the ability of UCP2 to diminish free radicals in macrophages (8) suggests that if that were the case in neurons as well, UCP2 activation may protect neurons in degenerative processes associated with free radical toxicity, such as occurring during epilepsy (25, 26) . In agreement with our proposition that UCP2 may be neuroprotective in the brain (17), we found a negative correlation between activation of an apoptotic signal, caspase 3, and UCP2 expression levels in neurons during acute brain injury (19). We also revealed that in the primate substantia nigra, where UCP2 is expressed (27), elevation of nigral state 4 respiration precedes protection of dopamine cells by a cofactor of UCP2, CoQ10, in a model of Parkinson's disease (27) . Thus, we hypothesize that induction of UCP2 is a general defense mechanism in neurodegenerative processes (28).
The goal of our present study was to demonstrate conclusively whether UCP2 expression supports neuronal survival in degenerative processes. We have used a combination of in vitro and in vivo models. An animal model of epilepsy was chosen in which, before the insult, UCP2 induction could be accomplished. The data reveal that increasing UCP2 expression before the onset of increased cellular stress robustly enhances the survival of neurons. 500 ng green fluorescence protein (GFP; Pway, a gift from Dr. T. Hughes) or 500 ng GFP plus 500 ng human UCP2 (hUCP2) (2) expression plasmids using Lipofectamine 2000 (Life Technologies, Inc., Grand Island, NY). After 2-3 d cells were washed with serum-free medium and exposed for 3 h to either 50 m H 2 O 2 or 1-5 mm sodium nitroprusside as a source of nitric oxide (NO). Cell survival was scored as the number of fluorescing cells in three random microscopic fields per well and was expressed as a percentage of untreated wells. Expression of hUCP2 in cells was tested by RT-PCR using isoform-specific primers.
Animals
For the rodent studies, C57BL/6J male mice were used. Transgenic animals were produced as described previously (29). In short (described in great detail in Ref. 29), an 80-kb human bacterial artificial chromosome (BAC) clone containing the natural genes and promoters was used to produce transgenic mice that slightly overexpress UCP2 and -3.
Transgenic animals and wild-type littermates were used from the sixth or higher backcross generation. All experimental procedures were approved by the institutional animal care and use committee of Yale University.
Induction of epileptic seizures
Animals were injected ip with 1 mg/kg scopolamine, followed 30 min later by ip pilocarpine (280 mg/kg) or vehicle. Animals and their seizure patterns were closely monitored in the following 24 h. Observers were blinded to the experimental group. These animals were killed 24 h after the induction of seizures.
Analysis of UCP2 mRNA
RT-PCR was used to assess UCP2 mRNA levels in seized and control animals and transgene (hUCP2 and hUCP3) expression in various brain regions. Total RNA was extracted, and cDNA was prepared as previously described (30). The primers used to amplify both mouse and hUCP2 were 5Ј-CTACAAGACCATTGCACGAGAGG-3Ј (forward) and 5Ј-AGCTGCTCATAGGTGACAAACAT-3Ј (reverse) and gave a 396-bp product. The primers used to detect hUCP2 were 5Ј-CCGTGAGACCT-TACAAAGC-3Ј (forward) and 5Ј-GGGAGCCTCTCGGGAAGTG-3Ј (reverse) and gave a 1046-bp product. The primers used to detect hUCP3 were 5Ј-AGGCGGTCCAGACGGCCCGGCT-3Ј (forward) and 5Ј-GGGGCTGAAGTACTGGCCTGGAGGT-3Ј (reverse). A 603-bp fragment of ␤-actin was amplified as a control (30). The PCR reaction was performed as previously described (17, 19, 29) . Reactions were analyzed by gel electrophoresis, and the identity of the bands was confirmed by sequencing of selected samples.
Detection of UCP2 in the hippocampus of transgenic animals
In situ hybridization for UCP2 was performed as described previously (17). The PCR product was inserted in Bluescript vector and subcloned. Linearized DNA was transcribed using T7 polymerase (antisense cRNA probe) and T3 polymerase (sense cRNA probe; Riboprobe Combination System T3/T7, Promega, Madison, WI). The radiolabeled cRNA probe was purified by passing the transcription reaction solution over a G-50 column (Amersham Pharmacia Biotech, Piscataway, NJ), and fractions were collected and counted using a scintillation counter. The purified cRNA probes were heated at 80 C for 2 min with 500 mg/ml yeast tRNA and 50 mm dithiothreitol in water before being diluted to an activity of 5.0 ϫ 10 7 dpm/ml with hybridization buffer containing 50% formamide, 0.25 m sodium chloride, 1ϫ Denhardt's solution, and 10% dextran sulfate. The brains of wild-type (n ϭ 3) and transgenic (n ϭ 3) animals were perfused and frozen on dry ice. The frozen brains were allowed to equilibrate in a cryostat at Ϫ20 C. Coronal sections containing the hippocampus were cut at 16 m and then mounted onto poly-llysine-coated slides. Sections with this hybridization solution (150 l/ slide) were incubated overnight at 50 C. After hybridization, the slides were washed four times (10 min each) in 4ϫ standard saline citrate (SSC) before ribonuclease digestion (20 g/ml for 30 min at 37 C) and rinsed at room temperature in decreasing concentrations of SSC that contained 1 mm dithiothreitol (2, 1, and 0.5ϫ; 10 min each) to a final stringency of 0.1ϫ SSC at 65 C for 30 min. After dehydration in increasing alcohols, the sections were exposed to ␤-max Hyperfilm (Amersham) for 5 d before being dipped in Kodak (Eastman Kodak, Rochester, NY) NTB-2 liquid emulsion diluted 1:1 with distilled water. The dipped autoradiograms were developed 21 d later with Kodak D-19 developer and fixed, and the sections were counterstained through emulsion with hematoxylin. Sections were examined under bright-and darkfield illumination. As a control experiment, sections were incubated as described above with hybridization solution containing the sense strand probe synthesized with T3 polymerase to transcribe the coding strand of the DNA insert.
Hippocampi of transgenic and wild-type mice were immunostained with UCP2 antisera using the avidin-biotin peroxidase method in which diaminobenzidine was used to visualize tissue-bound peroxidase (17-19). We used different antisera, including one (C-20, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) that we have previously observed to label a specific band around 33 kDa. This labeling was missing in UCP2 knockout animals, supporting the specificity of this antiserum (31).
Analysis of uncoupling activity
To test the level of mitochondrial uncoupling, oxygen consumption in state 3 and state 4 respiration and the respiratory control ratio (RCR: the ratio of these levels) were assessed as described previously (29, 31) from hippocampi of mice that were either intact or underwent seizures. In short, dissected hippocampi of control and seized animals (24 h after the initiation of seizures) were homogenized in a medium containing 320 mm sucrose, 10 mm Tris, and 1 mm EGTA adjusted to pH 7.4 with HCl. The samples were diluted 10 times with isolation medium. Oxygen consumption was determined using a Clark-type oxygen electrode in an incubation medium containing 80 mm KCl, 50 mm HEPES (pH 7), 1 mm EGTA, 5 mm K 2 HPO 4 , 4 m rotenone, 80 ng/ml nigericine, and 1 g/ml oligomycin using a saturating amount of succinate as substrate at 37 C. State 3 respiration was initiated by the addition of ADP (300 m), and subsequently, state 4 and 3 respiration and RCR were assessed.
Histological analyses
Twenty-four hours after the initiation of seizures, groups of animals were transcardially perfused under ether anesthesia with saline, followed by fixative containing 4% paraformaldehyde, 15% picric acid, and 0.1% glutaraldehyde.
The unbiased stereological methods for cell number assessment used a systematic random sampling method and met the statistical requirements necessary to ensure an unbiased estimate of the feature of interest. We chose to sample every 10th section (30 m thick) to assess cell number; the starting point of the series for each animal was randomly selected from the first 10 sections. Each electron micrograph of 1 section covered 1,800 m 2 , and each animal provided 8 samples. Thus, cell number was calculated for each experimental group as number per 14,400 m 2 . Calculations of mitochondrial number were performed in the stratum radiatum and the principal layer of the CA1 region of the hippocampus using unbiased ultrastructural analyses. In this, to obtain a comparable measure of cell and mitochondria numbers, unbiased for possible changes in size, the dissector technique was used. The number of mitochondria was counted in parallel consecutive serial sections with the help of a reference grid superimposed on the electron microscope photographs. The dissector volume (volume of reference) was the area of the reference grid multiplied by the distance between the upper faces of the reference and look-up sections. Section thickness was determined using Small's fold method.
Because an F test analysis of cell and mitochondria counts in different experimental and control groups revealed a significant nonhomogeneity of variances between groups, the Kruskal-Wallis one-way nonparametric ANOVA test was selected for statistical comparisons. A level of confidence of P Ͻ 0.05 was adopted.
Biochemical measurements

Assay for thiobarbituric acid (TBA)-reactive substances (TBARS).
To assess tissue levels of superoxides in the cortex and hippocampus, the TBARS assay was employed as described previously (32). Homogenates of dissected areas (1:10, wt/vol) were prepared immediately before use in ice-cold aqueous 20 mm Tris-HCl buffer, pH 7.4, using a Teflon pestle motor homogenizer. Lipid peroxidation was stimulated in assays containing 100 l homogenate by the addition of 10 l 100 m Fe 3ϩ (ammonium ferric sulfate) solution, and the mixture was incubated for 30 min at 37 C. The reaction was stopped by the addition of sodium dodecyl sulfate [100 l of an 8.1% (wt/vol) solution] and 750 l 20% acetic acid (adjusted to pH 3.5 using NaOH). Precipitated proteins were then removed by centrifugation at 10,000 ϫ g for 15 min. Aliquots (500 l) of the clear supernatant were heated in glass tubes capped with aluminum foil with an equal volume of TBA solution (0.8%, wt/vol; heated at 60 C to dissolve) at 95 C for 30 min. Samples were cooled on ice, 100 l of each were pipetted into 96-well plates, and absorbance was read at 532 nm using a Ceres UV 900C microplate reader. Blank values representing samples containing 20 mm Tris-HCl were subtracted from all values. Each assay was performed in triplicate. Means of triplicates from each assay were pooled to obtain the final mean and se. Typical TBARS formation in control brain and brain homogenates plus Fe 3ϩ (100 m) were calculated from the absorbance at 532 nm using 1,1,3,3-tetramethoxypropane as an external standard. Assay sensitivity was estimated from the standard curve, and a t test with two-tailed probabilities was employed for statistical comparisons.
Measurement of high energy phosphates in the brain. ATP, ADP, and AMP levels were assessed by HPLC analysis of regions of rapidly frozen tissues dissected at Ϫ30 C as described previously (33). In short, immediately after decapitation, whole brains and skull were immersed in liquid nitrogen and then dissected at Ϫ30 C to minimize the metabolism of high energy phosphates due to stress or declining oxygen levels. The apparatus consisted of a PerkinElmer (Norwalk, CT) gradient HPLC pump, a Waters Associates (Milford, MA) 409 multiple UV wavelength detector, and a Shimadzu 501 integrator (Tokyo, Japan). Frozen tissue was dissected on a freezing cold plate (Ϫ20 C), placed in 0.4 m perchloric acid (10 l/mg wet weight), homogenized, and centrifuged. The supernatant was neutralized with 25 l 2 m K 2 CO 3 added to 200 l supernatant and centrifuged. The supernatant was stored at Ϫ80 C until injected. Standards were prepared in 0.4 m perchloric acid at concentrations of 5 m. Samples were separated on a 15-cm 3-m Nikko Bioscience C 18 HPLC column (ESA, Inc., Chelmsford, MA) at a flow rate of 1 ml/min using a gradient. Buffer A was 25 mm Na 2 HPO 4 with 100 mg/liter TBA, pH 5.5, and buffer B was 200 mm Na 2 HPO 4 with 100 mg/liter TBA, pH 4.0, and 10% acetonitrile. The gradient was 100% buffer A for 0 -5 min, 100% buffer A to 100% buffer B for 5-25 min, and 100% buffer B for 25-34 min. Samples were monitored at 214 nm for 0 -9 min, 260 nm for 9 -25 min, and 214 nm for 25-34 min.
Lactate measurements. Tissue lactate was measured from the same samples as those for high energy phosphate measurements using a commercially available ELISA kit (Sigma-Aldrich Corp., St. Louis, MO).
Results
In vitro cell culture
UCP2 protects PC12 cells. To test the role of UCP2 directly on cell survival, we transfected excitable pheochromocytoma PC12 cells with a full-length hUCP2 cDNA and measured their responses to H 2 O 2 and NO, agents known to induce rapid cell death via free radical formation (34 -36). As PC12 cells express little or no UCP2 under normal growth conditions, only the transfected cells contained UCP2 mRNA (Fig.  1A) . We found significantly less death in UCP2-transfected vs. control PC-12 cells after exposure to either H 2 O 2 or NO (Fig. 1, B-E) , providing direct in vitro evidence that the expression of UCP2 is protective.
In vivo epilepsy model using transgenic mice expressing hUCP2
UCP2 mRNA and mitochondrial uncoupling are induced in hippocampus of mice after seizures. RT-PCR analysis did not detect UCP2 transcripts in the hippocampus of control mice, but these were clearly present 24 h after seizure induction (Fig.  2) . To test whether UCP2 induction in the mouse hippocampus has metabolic consequences, we assessed the RCRs of control and experimental mice. The RCR is the oxygen consumption at state 3 respiration (phosphorylating mitochondria) divided by the oxygen consumption at state 4 respiration (nonphosphorylating mitochondria in which oxygen consumption is due exclusively to proton leak, i.e. uncoupling). Lower RCR values correspond to higher mitochondrial uncoupling. In support of UCP2 being functionally active, the mean RCR of animals that seized was significantly lower than that of controls (1.73 Ϯ 0.1 vs. 2.34 Ϯ 0.06; P Ͻ 0.05).
UCP2 expression in the hippocampus of transgenic animals.
hUCP2 RNA was detected in the cerebellum, midbrain, brainstem, and cortex of transgenic, but not wild-type, mice (Fig. 3A) . In the hippocampus, including the CA1 region, no UCP2 mRNA could be detected by in situ hybridization in wild-type mice (Fig. 3, B and C) . In contrast, in transgenic mice, we found that UCP2 mRNA was associated with the pyramidal cell layer (Fig. 3, D labeling was also present in pyramidal cells of the hippocampus of transgenic (Fig. 3, H and I ), but not wild-type (Fig. 3,  F and G) , animals. The observations on wild-type mice are consistent with earlier reports on the lack UCP2 mRNA expression in the cortex and hippocampus of mice (16). The hUCP2 transgene expression in the hippocampus of intact animals provides an excellent model to test whether elevated UCP2 levels before initiation of seizures may be protective or detrimental for hippocampal neurons.
and E). UCP2-like immuno-
UCP2 is neuroprotective in a mouse model of epileptic seizures.
The UCP2 transgenic animals are on a C57/BL6 background that is resistant to kainic acid-induced seizures (37) and repeatedly delivered nonhomogenous responses to steady doses of kainic acid among wild-type animals. We therefore studied an alternative model in which seizure activity is induced by systemic scopolamine (1 mg/kg) and subsequent pilocarpine (280 mg/kg) injections, allowing noninvasive induction of motor seizures (38). In both wild-type (n ϭ 12) and transgenic (n ϭ 12) littermates, ip administration of pilocarpine resulted in the development of motor seizures within 10 -20 min after the initiation of treatment. The severity of motor seizures did not significantly differ between experimental groups, and both groups continued to manifest motor seizures in the hours following treatment, with seizure activity in this period showing no obvious difference between animal types (data not shown).
The observed seizure patterns in surviving transgenic and wild-type animals predict massive neuronal death in the hippocampal formation within 24 h, including the CA1 region (38). Indeed, tissue damage in the CA1 region was obvious in wild-type animals even by low power light microscopic survey (Fig. 4B) . Strikingly, however, the structure of the hippocampus of equally seized, transgenic mice was robustly less damaged (Fig. 4C) , more closely resembling that of the intact (Fig. 4A) than the wild-type seized animals (Fig. 4B ). This differential tissue damage was also confirmed by electron microscopic analysis (Fig. 4, D-F) . Quantitative ultrastructural analyses of the CA1 region revealed that the number of degenerating or apoptotic pyramidal cells was higher (Fig. 5 ) in wild-type animals (n ϭ 5) than transgenic littermates (n ϭ 5; P Ͻ 0.05). In randomly selected electron micrographs of the CA1 pyramidal cell layer (14,400 m 2 / animal), wild-type animals had 724 Ϯ 34 (Ϯsem) neurons, of which 365 Ϯ 18 (50.4%) were necrotic or apoptotic, and the transgenic animals had 808 Ϯ 41 total neurons, of which 75 Ϯ 5 (9.2%) were dying. In the transgenic animals, no significant cell death was apparent in other parts of the hippocampus, including the dentate gyrus and CA3 and CA2 areas. Although there were slightly more neurons in the principal layer of CA1 region of transgenic animals compared with wild-type mice (808 Ϯ 41 vs. 724 Ϯ 34), this difference did not reach significance (P Ͼ 0.05). No differences were detected in the volume of the entire brain or the hippocampal formation between transgenic and wild-type animals.
UCP2 decreases lipid peroxidation.
A potentially significant effect of UCP2 in neuroprotection may be its ability to control free radical production (7, 8) . To test whether free radical levels are affected in hUCP2-expressing mice, we analyzed lipid peroxidation in hippocampal and cerebral cortical homogenates from wild-type (n ϭ 6) and hUCP2-expressing (n ϭ 6) transgenic animals. TBARS assay revealed significantly lower levels of free radical content in the hippocampus of transgenic mice compared with wild-type littermates (15.14 Ϯ 1.106 vs. 20.18 Ϯ 1.81 nm 1,1,3,3-tetramethoxypropane/mg tissue; P Ͻ 0.05; Fig. 6A ). The vulnerability of neurons to oxidative and free radical stress may be lower in transgenic animals, due in part to decreased production and consequent increased buffering capacity of UCP2-expressing cells to reactive oxygen species.
UCP2 elevates ATP and ADP levels. When oxidation is uncoupled from phosphorylation, it might be anticipated that
hUCP2 transgene is present in intact transgenic animals. A, hUCP2 mRNA expression in the cerebellum (Ce), midbrain (Mid), brainstem (BS), and cortex (Ctx) of intact transgenic and wild-type animals. hUCP3 mRNA was undetectable in any of the regions. B-E, In situ hybridization histochemistry demonstrated no UCP2 mRNA expression in the CA1 region of wild-type animals (B and C), but it was expressed in the pyramidal layer of the CA1 region of transgenic animals (D and E). C and E, High-power magnifications of the pyramidal layer shown on D and E, respectively. Silver grains exceeding three times the background level around counterstained nuclei were considered as a cell with UCP2 mRNA labeling. The bar scale in D represents 50 m for B and D. The bar scale in E represents 10 m for C and E. F-I, Immunocytochemistry for UCP2 using antisera that cross-react with hUCP2 resulted in no specific labeling in the CA1 region of wild-type animals (F and G). In transgenic animals, immunolabeling was detected in principal cells (H and I) that resembled pyramidal cells (pyr; arrowheads). A high-power magnification (I) showed that immunoperoxidase was also associated with dendrites extending to the stratum radiatum (str). The bar scale in H represents 50 m for F and H. The bar scale in I represents 10 m for G and I.
ATP production would be compromised in mitochondria, which, in turn, could lead to cell death rather than survival (26). To determine ATP and ADP levels in hUCP2-expressing mice (n ϭ 5) and wild-type littermates (n ϭ 5), we analyzed freeze-clamped brain tissue for AMP, ADP, and ATP by HPLC. Strikingly, we found a nearly 60% increase in ATP (P Ͻ 0.05) and a 30% increase in ADP (P Ͻ 0.05) levels in the brains of hUCP2-expressing mice compared with wild-type littermates (Fig. 6C) . One explanation for this may be that decreased yield of ATP production by respiration is balanced by an increased rate of ATP production by glycolysis, but no significant difference was found between brain lactate levels in transgenic (n ϭ 5) and wild-type (n ϭ 5) animals (29.36 Ϯ 3.87 vs. 33.16 Ϯ 9.80 nmol/mg protein; P ϭ 0.55). Although these measurements cannot detect more complex changes in the rate of lactate metabolism, they do not support the argument that increased ATP levels in UCP2-overexpressing animals are the result of increased glycolysis.
UCP2 increases mitochondrial number. In a recent study, PGC-1 (peroxisome-proliferator activated receptor ␥ coactivator-1␣), a cold-induced transcription factor, was shown to upregulate the expression of UCPs, including UCP2, and to induce mitochondrial proliferation (39). To test whether by partially uncoupling respiration from oxidative phosphorylation, UCP2 might trigger mitochondrial proliferation, we assessed mitochondria number and size in the CA1 region of the hippocampus by stereological quantification. We found that the number of mitochondria was significantly higher in the hippocampus of UCP2 transgenic animals (n ϭ 5) compared with wild-type littermates (n ϭ 5; Fig. 6 , B, D, and E). In the principal layer of CA1 of wild-type animals, 651 Ϯ 38 (wild-type) and 1425 Ϯ 72 (transgenic) mitochondria were counted within a 3600-m 2 region. This represented a 218% increase (P Ͻ 0.05) in mitochondria number. In the stratum radiatum of the CA1 region, the mean numbers of mitochondria were 1584 Ϯ 82 (wild-type) and 2364 Ϯ 102 (transgenic), which also represented a significant (P Ͻ 0.05) increase (150%) in transgenic animals. Because hUCP2 mRNA and protein were expressed in pyramidal cell and their dendrites, these observations suggest that UCP2 can lead to the production of more mitochondria, and this may be the basis for the observed increases in ATP and ADP levels.
Discussion
Our in vitro and in vivo results both show that increased expression of UCP2 protects neurons against a variety of noxious insults. Although the functionality of UCP2 remains controversial in different tissue types, for example, in the spleen (40, 41), our present observations are supportive of the idea that UCP2 has significant impact on physiological and pathological processes.
Transfection of PC12 cells by UCP2 decreased the death of cells exposed to either H 2 O 2 or NO, substances shown to be toxic via their free radical metabolites (34 -36). Similar mech- anisms of apoptosis induction have been implicated in epileptic insults (25, 42-44), and thus, they could have contributed to the in vivo results as well. In addition, the increased in vivo survival of neurons in the hippocampus of epileptic rodent brain expressing hUCP2 constitutively may be mediated by an increase in the number of mitochondria. UCP levels are also positively correlated with mitochondrial number in brown fat (UCP1) (45) and with ATP amounts in muscle (46), but are negatively correlated with ATP levels in pancreatic ␤-cells in vitro (47). Thus, it is not unlikely that UCP2's effect on mitochondrial proliferation and ATP production may be tissue specific. What the downstream molecular events are after UCP2 activation to trigger mitochondrial proliferation remains to be resolved. Nevertheless, it is tempting to speculate that the subtle lowering of inner mitochondrial membrane potential by UCP2 activation compromises the efficacy of a mitochondrion to produce ATP, which may, in turn, activate signaling cascade between the mitochondrion to the host nucleus for the need of more ATP sources, i.e. mitochondria.
The idea that mitochondrial proliferation is important in neuronal survival during epilepsy is supported by the observation that in epileptic hippocampus of humans, the number of mitochondria in surviving neurons is elevated (48). The partially uncoupled, more numerous mitochondria thus can produce the same or larger amounts of ATP than the normal number of tightly coupled mitochondria of wild-type animals without a corresponding increase in free radical production (Fig. 7) . Indeed, the suppressed lipid peroxidation that we observed in the brains of transgenic animals with higher mitochondrial numbers and ATP levels are likely to be the consequences of diminished free radical levels, because UCP2 uses these reactive oxygen species to increase their proton conductance (13, 14) , a process that also eliminates these very free radicals (present results, but also see Refs. 7 and 8). Because of this and the fact that UCP2 can be induced by increased cellular stress during brain injury (19), it is reasonable to suggest that the mechanism depicted in Fig. 7 can underlie preconditioning of neuronal tissue by repeated low exposure of neurons to cellular stress in which UCP2 is induced. Whether the same mechanism of preconditioning by UCP2 may exist in other tissues, for example, in the heart, needs to be tested in future studies.
The last decade has provided overwhelming evidence that mitochondrial proteins, in addition to participating in energy production, act as initiating elements of cellular death by either apoptosis or necrosis (49 -51). Failure of the integrity of the inner and outer membranes (and the collapse of membrane potentials) of the mitochondria are among the first critical steps in initiating neuronal cell death. Our present data together with the pioneering work of Nicholls and coworkers (21-24) suggest that UCP2, by stabilizing mitochondrial membrane potential, may avoid disintegration of the inner mitochondrial membrane, which, in turn, prevents the likelihood of cell death. The cytotoxic and/or excitotoxic damage to neurons induced by epileptic seizures has similarities to that seen in a variety of other neurological disorders ranging from stroke to Alzheimer's disease. We suggest that increased UCP2 activity could provide protection in these disorders. In fact, recently we have established that increased mitochondrial uncoupling predicts decreased cell death in acute brain injury (19) as well as in a nonhuman primate model of Parkinson's disease (27). Because there is good evidence that UCP2 activity can be regulated at both transcriptional and posttranslational levels (13) (14) (15) , it is an excellent candidate to target for the development of novel therapies for these disorders. On the other hand, when UCP2 down-regulation is designed to affect peripheral mechanisms, including insulin secretion (43) or the innate immune system (8), profound side-effects of those treatments might occur that could trigger or worsen neurodegenerative processes.
FIG. 7.
Schematic illustration of UCP2 action based on our results. In control animals (left), a proton gradient in tightly coupled mitochondria drives ATP synthesis through ATP synthase, and as a consequence, free radical oxygen species are produced. In transgenic animals (right), increased expression of UCP2 leads to leakage of protons across the inner mitochondrial membrane, which more efficiently neutralizes the free radical oxygen. Although this may be associated with less efficient ATP production per mitochondrion, the increased number of mitochondria results in an overall increased level of ATP with reduced free radical oxygen production.
